Bendamustine Hydrochloride 10019-0079-01
- Manufacturer
- Baxter Healthcare Corporation
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 15, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA216078
Need to source Bendamustine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bendamustine Hydrochloride | 100 mg/1 |
Drug Class
Alkylating Activity [MoA]Alkylating Drug [EPC]
Selected Package
10019-0079-01Selected1 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE